The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody
Abstract
Background— Reperfusion therapy for myocardial infarction is hampered by detrimental inflammatory responses partly via Toll-like receptor (TLR) activation. Targeting TLR signaling may optimize reperfusion therapy and enhance cell survival and heart function after myocardial infarction. Here, we evaluated the role of TLR2 as a therapeutic target using a novel monoclonal anti-TLR2 antibody. Method and Results— Mice underwent 30 minutes of ischemia followed by reperfusion. Compounds were administered 5 minutes before reperfusion. Cardiac function and dimensions were assessed at baseline and 28 days after infarction with 9.4-T mouse magnetic resonance imaging. Saline and IgG isotype treatment resulted in 34.5±3.3% and 31.4±2.7% infarction, respectively. Bone marrow transplantation experiments between wild-type and TLR2-null mice revealed that final infarct size is determined by circulating TLR2 expression. A single intravenous bolus injection of anti-TLR2 antibody reduced infarct size to 18.9±2.2% ( P =0.001). Compared with saline-treated mice, anti-TLR2–treated mice exhibited less expansive remodeling (end-diastolic volume 68.2±2.5 versus 76.8±3.5 μL; P =0.046) and preserved systolic performance (ejection fraction 51.0±2.1% versus 39.9±2.2%, P =0.009; systolic wall thickening 3.3±6.0% versus 22.0±4.4%, P =0.038). Anti-TLR2 treatment significantly reduced neutrophil, macrophage, and T-lymphocyte infiltration. Furthermore, tumor necrosis factor-α, interleukin-1α, granulocyte macrophage colony-stimulating factor, and interleukin-10 were significantly reduced, as were phosphorylated c-jun N-terminal kinase, phosphorylated p38 mitogen-activated protein kinase, and caspase 3/7 activity levels. Conclusions— Circulating TLR2 expression mediates myocardial ischemia/reperfusion injury. Antagonizing TLR2 just 5 minutes before reperfusion reduces infarct size and preserves cardiac function and geometry. Anti-TLR2 therapy exerts its action by reducing leukocyte influx, cytokine production, and proapoptotic signaling. Hence, monoclonal anti-TLR2 antibody is a potential candidate as an adjunctive for reperfusion therapy in patients with myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Murphy, E., & Steenbergen, C. (2008) · Physiological Reviews · doi:10.1152/physrev.00024.2007 · Cited by 1,465
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., Cung, T. T., Bonnefoy, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Cannon, C. P. (2000) · JAMA · doi:10.1001/jama.283.22.2941 · Cited by 1,222
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog.
Jennings, R. B., Hm, S., Ga, S., Ha, F., & LINN, H. (1960) · PubMed · Cited by 773
Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
Frantz, S., Kobzik, L., Kim, Y.-D., Fukazawa, R., Medzhitov, R., Lee, R. T., & Kelly, R. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6709 · Cited by 645
The immune system and cardiac repair
FRANGOGIANNIS, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.007 · Cited by 641
Ross, A. M., Gibbons, R. J., Stone, G. W., Kloner, R. A., & Alexander, R. W. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.061 · Cited by 610
Faure, E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., Kirschning, C. J., Polentarutti, N., Muzio, M., & Arditi, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11058 · Cited by 560
Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 513
Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy
Bolli, R., Becker, L., Gross, G., Mentzer, R., Balshaw, D., & Lathrop, D. A. (2004) · Circulation Research · doi:10.1161/01.res.0000137171.97172.d7 · Cited by 428
BOYD, J., MATHUR, S., WANG, Y., BATEMAN, R., & WALLEY, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.011 · Cited by 372
Timmers, L., Sluijter, J. P. G., van Keulen, J. K., Hoefer, I. E., Nederhoff, M. G. J., Goumans, M.-J., Doevendans, P. A., van Echteld, C. J. A., Joles, J. A., Quax, P. H., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.158220 · Cited by 344
Self-citationToll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction
Shishido, T., Nozaki, N., Yamaguchi, S., Shibata, Y., Nitobe, J., Miyamoto, T., Takahashi, H., Arimoto, T., Maeda, K., Yamakawa, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101921.93016.1c · Cited by 303
Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration
Libby, P., Maroko, P. R., Bloor, C. M., Sobel, B. E., & Braunwald, E. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107221 · Cited by 293
Deleterious effects of methylprednisolone in patients with myocardial infarction.
Roberts, R. E., deMELLO, V. R., & Be, S. (1976) · PubMed · Cited by 277
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Chao, W. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00995.2008 · Cited by 245
Signalling of Toll-Like Receptors
Brikos, C., & O'Neill, L. A. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_2 · Cited by 192
Self-citationFavre, J., Musette, P., Douin-Echinard, V., Laude, K., Henry, J.-P., Arnal, J.-F., Thuillez, C., & Richard, V. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.140723 · Cited by 159
Letter: Pacing the WPW patient.
Goldstein, S. (1976) · Circulation · doi:10.1161/01.cir.53.1.204 · Cited by 128
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Sakata, Y., Dong, J.-W., Vallejo, J. G., Huang, C., Baker, J. S., Tracey, K. J., Tacheuchi, O., Akira, S., & Mann, D. L. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00642.2006 · Cited by 122
Gao, F. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00488-6 · Cited by 115
Feng, Y., Zhao, H., Xu, X., Buys, E. S., Raher, M. J., Bopassa, J. C., Thibault, H., Scherrer‐Crosbie, M., Schmidt, U. H., & Chao, W. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00119.2008 · Cited by 107
HMGB1 preconditioning: therapeutic application for a danger signalõ
Klune, J. R., Billiar, T. R., & Tsung, A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607406 · Cited by 30
Cited by
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., Salto-Tellez, M., Timmers, L., Lee, C. N., El Oakley, R. M., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.12.003 · Cited by 2,215
Self-citationThe inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Regulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194
Metadata
- Authors
- Arslan, F., Smeets, M. B., O'Neill, L. A. J., Keogh, B., McGuirk, P., Timmers, L., Tersteeg, C., Hoefer, I. E., Doevendans, P. A., Pasterkamp, G., & de Kleijn, D. P. V.
- Venue
- Circulation
- Published
- 2010-01-05
- Volume
- 121
- Issue
- 1
- Pages
- 80-90
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2147284855
- Cited by
- 358
- References
- 25
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.